Rosamaria Orlando
Pozzilli, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Endogenous Activation of mGlu5 Metabotropic Glutamate Receptors Is Required for Oligodendrocyte Maturation and Myelinogenesis in Mice.
Journal: Cells
Published: April 23, 2026
Preclinical and clinical study on type 3 metabotropic glutamate receptors in Parkinson's disease.
Journal: NPJ Parkinson's disease
Published: July 26, 2024
Metabotropic Glutamate Receptors Type 3 and 5 Feature the "NeuroTransmitter-type" of Glioblastoma: A Bioinformatic Approach.
Journal: Current neuropharmacology
Published: June 06, 2023
GPCR interactions involving metabotropic glutamate receptors and their relevance to the pathophysiology and treatment of CNS disorders.
Journal: Neuropharmacology
Published: January 30, 2023
Blunted type-5 metabotropic glutamate receptor-mediated polyphosphoinositide hydrolysis in two mouse models of monogenic autism.
Journal: Neuropharmacology
Published: July 25, 2022
Synergic action of L-acetylcarnitine and L-methylfolate in Mouse Models of Stress-Related Disorders and Human iPSC-Derived Dopaminergic Neurons.
Journal: Frontiers in pharmacology
Published: April 05, 2022
Changes in mGlu5 Receptor Signaling Are Associated with Associative Learning and Memory Extinction in Mice.
Journal: Life (Basel, Switzerland)
Published: February 20, 2022
The bacterial quorum sensing molecule, 2-heptyl-3-hydroxy-4-quinolone (PQS), inhibits signal transduction mechanisms in brain tissue and is behaviorally active in mice.
Journal: Pharmacological research
Published: February 17, 2021
mGlu3 receptor regulates microglial cell reactivity in neonatal rats.
Journal: Journal of neuroinflammation
Published: April 14, 2020
Targeting mGlu Receptors for Optimization of Antipsychotic Activity and Disease-Modifying Effect in Schizophrenia.
Journal: Frontiers in psychiatry
Published: November 13, 2018
In Vivo Non-radioactive Assessment of mGlu5 Receptor-Activated Polyphosphoinositide Hydrolysis in Response to Systemic Administration of a Positive Allosteric Modulator.
Journal: Frontiers in pharmacology
Published: May 09, 2018
Letter: the addition of an immunosuppressant in patients with unsatisfactory response to vedolizumab.
Journal: Alimentary pharmacology & therapeutics
Published: March 08, 2018
Last Updated: 09/26/2026